Cure Arthritis Naturally

Beat Arthritis Naturally

Get Instant Access

1. McCluskey P, Towler HM, Lightman S. Management of chronic uveitis. Br Med J 2000; 320 (7234):555-558.

2. Wakefield D, Chang JH. Epidemiology of uveitis. Int Opthalmol Clin 2005; 45(2):1-13.

3. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996; 80(9):844-848.

4. Couto C, Merlo JL. Epidemiological study of patients with uveitis in Buenos Aires, Argentina. In: Dernouchamps JP, Verougstraete C, Casper-Velu L, et al., eds. Recent Advances in Uveitis: Proceedings of the Third International Symposium on Uveitis, Brussels, Belgium, May 24-27, 1992. Amsterdam, New York: Kugler Publications, 1993:171-174.

5. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003; 3(11):879-889.

6. Pras E, Neumann R, Zandman-Goddard G, et al. Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum 2004; 34(3):602-609.

7. Chan CC, Li Q. Immunopathology of uveitis. Br J Ophthalmol 1998; 82(1):91-96.

8. Gasch AT, Smith JA, Whitcup SM. Birdshot retinochoroidopathy. Br J Ophthalmol 1999; 83(2): 241-249.

9. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363(9425):1965-1976.

10. Dutly F, Altwegg M. Whipple's disease and Tropheryma whippelli. Clin Microbiol Rev 2001; 14 (3):561-583.

11. American Academy of Pediatrics Section on Rheumatology and Section on Ophthalmology: Guidelines for ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 1993; 92(2):295-296.

12. Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, et al. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis 2005; 64(12):871-874.

13. Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004; 111(4):802-809.

14. Zamiri P, Boyd S, Lightman S. Uveitis in the elderly—is it easy to identify the masquerade? Br J Ophthalmol 1997; 81(10):827-831.

15. Sheu SJ. Update on uveomeningoencephalitides. Curr Opin Neur 2005; 18(3):323-329.

16. Jabs DA, Akpek EK. Immunosuppression for posterior uveitis. Retina 2005; 25(1):1—18.

17. Haynes BF, Kaiser-Kupfer MI, Mason P, et al. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 1980; 59(6):426-441.

18. Vollertsen RS, McDonald TJ, Younge BR, et al. Cogan's syndrome: 18 cases and a review of the literature. Mayo Clin Proc 1986; 61(5):344-361.

19. McCallum RM, Allen NB, Cobo LM, et al. Cogan's syndrome: clinical features and outcomes. Arthritis Rheum 1992; 35(suppl 9):S51.

20. Grasland A, Pouchot J, Hachulla E, et al. Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 2004; 43(8):1007-1015.

21. Dana MR. Corneal antigen-presenting cells: diversity, plasticity, and disguise: the Cogan lecture. Invest Ophthalmol Vis Sci 2004; 45(3):722-727.

22. Harris JP, Heydt J, Keithley EM, et al. Immunopathology of the inner ear: an update. Ann NY Acad Sci 1997; 830:166-178.

23. Yimtae K, Song H, Billings P, et al. Connection between the inner ear and the lymphatic system. Laryngoscope 2001; 111(9):1631-1635.

24. Hashimoto S, Billings P, Harris JP, et al. Innate immunity contributes to cochlear adaptive immune responses. Audiol Neurootol 2005; 10(1):35-43.

25. Fisher ER, Hellstrom HR. Cogan's syndrome and systemic vascular disease. Analysis of pathologic features with reference to its relationship to thromboangiitis obliterans (Buerger). Arch Pathol 1961; 72:572-592.

26. Rarey KE, Bicknell JM, Davis LE. Intralabyrinthine osteogenesis in Cogan's syndrome. Am J Otolaryngol 1986; 7(6):387-390.

27. Schuknecht HF, Nadol JB. Temporal bone pathology in a case of Cogan's syndrome. Laryngoscope 1994; 104(9):1135-1142.

28. Lunardi C, Bason C, Leandri M, et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002; 360(9337):915-921.

29. Allen NB, Cox CC, Cobo M, et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogans syndrome. Am J Med 1990; 88(3):296-301.

30. Statement on Sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160(2):736-755.

31. Henke CE, Henke G, Elveback LR, et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 1986; 123(5):840-845.

32. Grunewald J, Wahlstrom J, Berlin M, et al. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DR beta chain conformation. Thorax 2002; 57 (4):348-352.

33. King TE. Overview of Sarcoidosis: UpToDate 2005, 13.2.

34. deShazo RD, O'Brien MM, Justice WK, et al. Diagnostic criteria for sarcoidosis of the sinuses. J Allergy Clin Immunol 1999; 103(5 Pt 1):789-795.

35. Braun JJ, Gentine A, Pauli G. Sinonasal sarcoidosis: review and report of fifteen cases. Laryngoscope 2004; 114(11):1960-1963.

36. Kardon DE, Thompson LDR. A clinicopathologic series of 22 cases of tonsillar granulomas. Laryngoscope 2000; 110(3 Pt 1):476-481.

37. Fortune S, Courey MS. Isolated laryngeal sarcoidosis. Otolaryngol Head Neck Surg 1998;118(6):868-870.

38. Gerencer RZ, Keohane JD Jr, Russell L. Laryngeal sarcoidosis with airway obstruction. J Otolaryngol 1998; 27(2):90-93.

39. Shah UK, White JA, Gooey JE, et al. Otolaryngologic manifestations of sarcoidosis: presentation and diagnosis. Laryngoscope 1997; 107(1):67-75.

40. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol 2000; 84(1):110-116.

41. Adcock BB. Facial numbness: a manifestation of sarcoidosis. J Am Board Fam Pract 1999; 12(3):253-255.

42. Westlake, Heath JD, Spalton DJ. Sarcoidosis involving the optic nerve and hypothalamus. Arch Ophthalmol 1995; 113(5):669-670.

Was this article helpful?

0 0


Thank you for deciding to learn more about the disorder, Osteoarthritis. Inside these pages, you will learn what it is, who is most at risk for developing it, what causes it, and some treatment plans to help those that do have it feel better. While there is no definitive “cure” for Osteoarthritis, there are ways in which individuals can improve their quality of life and change the discomfort level to one that can be tolerated on a daily basis.

Get My Free Ebook

Post a comment